1-bromo-2-(bromomethyl)benzene | CAS:3433-80-5

We serve 1-bromo-2-(bromomethyl)benzene CAS:3433-80-5 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
1-bromo-2-(bromomethyl)benzene

Chemical Name:1-bromo-2-(bromomethyl)benzene
CAS.NO:3433-80-5
Synonyms:2-Bromobenzyl bromide
o-Bromobenzyl bromide
Molecular Formula:C7H6Br2
Molecular Weight:249.93100
 
Physical and Chemical Properties:
Density:1.849;
Melting point:29-32oC;
Boiling point:129oC;
Flash point:230oF;
Index of Refraction:1.619;
 
Specification:
Appearance:Yellowish to brownish red transparent liquid
Brownish red or off-white crystal at low temperature
Purity(GC):≥99.0%
Moisture:≤0.1%
2-Bromotoluene:≤0.5%
Other impurities:≤0.5%
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:As an intermediate in organic synthesis



Contact us for information like 1-bromo-2-(bromomethyl)benzene chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,o-Bromobenzyl bromide physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,1-bromo-2-(bromomethyl)benzene Use and application,o-Bromobenzyl bromide technical grade,usp/ep/jp grade.


Related News: From the perspective of the corresponding formulation manufacturer, the drug substance needs to meet the requirements of impurities and stability. The production base must pass the international quality system certifications such as cGMP and EuGMP. At the same time, the drug substance company must have sufficient capacity.toluene-4-sulfonic acid (R)-(tetrahydro-furan-3-yl) ester manufacturer In recent years, there has been a relatively concentrated concentration of intermediate companies listed on the capital market. Most of the fund-raising projects are aimed at breaking through the bottleneck of production capacity to meet growing demand, and the entire industry has shown a vigorous development momentum.1,12-Dodecanediol supplier ICIG has agreed to offer employment to the unit’s approximately 120 employees upon closing, and plans to maintain operations at its primary location, a manufacturing facility in Liestal, Switzerland.6-Quinolinecarboxylic acid, 4-chloro-7-methoxy-, methyl ester vendor Retrogenix and Resonant Therapeutics, Inc. recently announced they have entered into a non-exclusive strategic partnership to identify the targets of Resonant antibodies directed against the tumor microenvironment.In the context of the new medicine policy, with the development of China’s R & D strength, the number of innovative drugs approved has been blown out, which further strengthened the demand and speed of industrialization of raw materials in China.